NSE BSE
unichem laboratories ltd stock

UNICHEM LABORATORIES LTD Share Price

- - (%)
- NSE: UNICHEMLAB

UNICHEM LABORATORIES LTD Share Price Update

As of the latest trading session, UNICHEM LABORATORIES LTD share price is currently at 532.1, which is down by -3.00 from its previous closing. Today, the stock has fluctuated between 531.00 and 538.95. Over the past year, UNICHEM LABORATORIES LTD has achieved a return of 39.24 %. In the last month alone, the return has been -2.49 %. Read More...

UNICHEM LABORATORIES LTD Performance

Day Range

Low531.00 High538.95
531.75

52 Week Range

Low 375.65 High 615.65
531.75

UNICHEM LABORATORIES LTD Share Price

3579

506690

UNICHEMLAB

img img img img
No Data Available

Open Price

534.20

Prev. Close

535.10

Volume (Shares)

6531.00

Total traded value

34.72

Upper Circuit

642.10

Lower Circuit

428.10

Note: The current prices & values are delayed, Login to your account for live updates.

UNICHEM LABORATORIES LTD Fundamentals


(Standalone)

Market Cap (Cr) 3746.29
PE Ratio (TTM) 0.00
Book Value / Share 325.91
Beta 0.35
ROE -1.55%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -114.97

UNICHEM LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 399.24
Operating Expense 395.63
Net Profit -114.97
Net Profit Margin (%) -28.79
Earnings Per Share (EPS) -16.33
EBITDA -87.99
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 362.43
Operating Expense 371.08
Net Profit 69.30
Net Profit Margin (%) 19.12
Earnings Per Share (EPS) 9.85
EBITDA 97.28
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 333.83
Operating Expense 372.21
Net Profit -30.81
Net Profit Margin (%) -9.22
Earnings Per Share (EPS) -4.38
EBITDA 0.27
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 346.67
Operating Expense 368.20
Net Profit -15.70
Net Profit Margin (%) -4.52
Earnings Per Share (EPS) -2.23
EBITDA 14.14
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 310.06
Operating Expense 350.04
Net Profit -143.83
Net Profit Margin (%) -46.38
Earnings Per Share (EPS) -20.43
EBITDA -112.58
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 1442.17
Operating Expense 1507.13
Net Profit -92.18
Net Profit Margin (%) -6.39
Earnings Per Share (EPS) -13.09
EBITDA 23.69
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 1072.43
Operating Expense 1280.70
Net Profit -299.70
Net Profit Margin (%) -27.94
Earnings Per Share (EPS) -42.57
EBITDA -163.72
Effective Tax Rate (%) -7.38
Particulars MAR 2022 (Values in Cr)
Revenue 942.93
Operating Expense 1071.74
Net Profit -55.43
Net Profit Margin (%) -5.87
Earnings Per Share (EPS) -7.87
EBITDA -1.49
Effective Tax Rate (%) 36.10
Particulars MAR 2021 (Values in Cr)
Revenue 1123.97
Operating Expense 1105.70
Net Profit 54.08
Net Profit Margin (%) 4.81
Earnings Per Share (EPS) 7.68
EBITDA 142.84
Effective Tax Rate (%) 17.60
Particulars MAR 2020 (Values in Cr)
Revenue 904.44
Operating Expense 1067.42
Net Profit -56.32
Net Profit Margin (%) -6.22
Earnings Per Share (EPS) -8.00
EBITDA 8.56
Effective Tax Rate (%) 11.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 345.89
ROE % -7.05
ROCE % -4.51
Total Debt to Total Equity 0.13
EBITDA Margin -1.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 371.90
ROE % 1.22
ROCE % 0.88
Total Debt to Total Equity 0.09
EBITDA Margin 9.16
Particulars MAR 2021 (Values in Cr)
Book Value / Share 363.16
ROE % 1.05
ROCE % 1.66
Total Debt to Total Equity 0.06
EBITDA Margin 10.51
Particulars MAR 2020 (Values in Cr)
Book Value / Share 359.54
ROE % -3.34
ROCE % -2.36
Total Debt to Total Equity 0.08
EBITDA Margin 1.40
Particulars MAR 2019 (Values in Cr)
Book Value / Share 372.23
ROE % -1.58
ROCE % -2.41
Total Debt to Total Equity 0.07
EBITDA Margin -0.11
Particulars MAR 2024 (Values in Cr)
Book Value / Share 325.91
ROE % -1.55
ROCE % -1.05
Total Debt to Total Equity 0.04
EBITDA Margin 5.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 338.65
ROE % -7.77
ROCE % -5.88
Total Debt to Total Equity 0.05
EBITDA Margin -4.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 379.52
ROE % -2.06
ROCE % -3.03
Total Debt to Total Equity 0.02
EBITDA Margin -0.16
Particulars MAR 2021 (Values in Cr)
Book Value / Share 383.11
ROE % 2.02
ROCE % 2.47
Total Debt to Total Equity 0.00
EBITDA Margin 12.71
Particulars MAR 2020 (Values in Cr)
Book Value / Share 375.99
ROE % -2.09
ROCE % -2.30
Total Debt to Total Equity 0.00
EBITDA Margin 0.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 185.36
Total Assets 3193.04
Total Liabilities 3193.04
Total Equity 2435.30
Share Outstanding 70405750
Price to Book Ratio 0.85
Return on Assets (%) -6.33
Return on Capital (%) -7.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 114.10
Total Assets 3318.77
Total Liabilities 3318.77
Total Equity 2618.41
Share Outstanding 70405750
Price to Book Ratio 0.69
Return on Assets (%) 0.99
Return on Capital (%) 1.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 82.44
Total Assets 3125.71
Total Liabilities 3125.71
Total Equity 2556.83
Share Outstanding 70405750
Price to Book Ratio 0.81
Return on Assets (%) 1.09
Return on Capital (%) 1.29
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 233.81
Total Assets 3144.73
Total Liabilities 3144.73
Total Equity 2531.35
Share Outstanding 70405750
Price to Book Ratio 0.40
Return on Assets (%) -1.91
Return on Capital (%) -2.22
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 200.98
Total Assets 3149.61
Total Liabilities 3149.61
Total Equity 2619.90
Share Outstanding 70383250
Price to Book Ratio 0.50
Return on Assets (%) -0.75
Return on Capital (%) -0.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 129.05
Total Assets 2863.69
Total Liabilities 2863.69
Total Equity 2294.62
Share Outstanding 70405750
Price to Book Ratio 1.50
Return on Assets (%) -3.21
Return on Capital (%) -3.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 157.27
Total Assets 2886.13
Total Liabilities 2886.13
Total Equity 2384.27
Share Outstanding 70405750
Price to Book Ratio 0.85
Return on Assets (%) -10.38
Return on Capital (%) -12.06
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 99.03
Total Assets 3122.08
Total Liabilities 3122.08
Total Equity 2672.04
Share Outstanding 70405750
Price to Book Ratio 0.69
Return on Assets (%) -1.77
Return on Capital (%) -1.98
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 57.58
Total Assets 3119.05
Total Liabilities 3119.05
Total Equity 2697.33
Share Outstanding 70405750
Price to Book Ratio 0.81
Return on Assets (%) 1.73
Return on Capital (%) 2.01
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 205.37
Total Assets 3025.13
Total Liabilities 3025.13
Total Equity 2647.18
Share Outstanding 70405750
Price to Book Ratio 0.40
Return on Assets (%) -1.86
Return on Capital (%) -2.12
Particulars MAR 2023 (Values in Cr)
Net Income -176.36
Cash from Operations -72.88
Cash from Investing 202.81
Cash from Financing -81.29
Net change in Cash 36.42
Free Cash Flow -28.56
Particulars MAR 2022 (Values in Cr)
Net Income 21.96
Cash from Operations -251.99
Cash from Investing 102.39
Cash from Financing 191.22
Net change in Cash 34.01
Free Cash Flow -124.99
Particulars MAR 2021 (Values in Cr)
Net Income 51.47
Cash from Operations 47.34
Cash from Investing -73.55
Cash from Financing -121.07
Net change in Cash -161.65
Free Cash Flow 335.15
Particulars MAR 2020 (Values in Cr)
Net Income -48.21
Cash from Operations 24.15
Cash from Investing -35.91
Cash from Financing -62.29
Net change in Cash -78.39
Free Cash Flow 410.30
Particulars MAR 2019 (Values in Cr)
Net Income -57.43
Cash from Operations -315.57
Cash from Investing -286.00
Cash from Financing -2.41
Net change in Cash -616.19
Free Cash Flow -121.26
Particulars MAR 2024 (Values in Cr)
Net Income -92.18
Cash from Operations -41.41
Cash from Investing 53.23
Cash from Financing -48.06
Net change in Cash -36.39
Free Cash Flow -21.04
Particulars MAR 2023 (Values in Cr)
Net Income -279.08
Cash from Operations -117.23
Cash from Investing 202.49
Cash from Financing -61.75
Net change in Cash 23.40
Free Cash Flow -75.18
Particulars MAR 2022 (Values in Cr)
Net Income -86.74
Cash from Operations -162.36
Cash from Investing 106.31
Cash from Financing 95.80
Net change in Cash 43.80
Free Cash Flow -35.80
Particulars MAR 2021 (Values in Cr)
Net Income 65.64
Cash from Operations -32.30
Cash from Investing -80.38
Cash from Financing -45.07
Net change in Cash -158.07
Free Cash Flow 253.56
Particulars MAR 2020 (Values in Cr)
Net Income -63.81
Cash from Operations -44.48
Cash from Investing -35.58
Cash from Financing -21.01
Net change in Cash -98.44
Free Cash Flow 334.38
Company Name Price P/E P/B Market Cap 52 Week Low/High
UNICHEM LABORATORIES LTD 535.30 0.00 1.59 3768.82 374.10 / 616.00
BLISS GVS PHARMA LTD 116.40 12.72 1.26 1219.15 77.65 / 148.95
CIPLA LTD 1505.80 28.56 4.55 121596.06 1018.30 / 1581.70
FERMENTA BIOTECH LIMITED 203.65 0.00 2.07 599.36 136.00 / 219.05
GLAXOSMITHKLINE PHARMA LT 2559.65 66.04 24.39 43362.02 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
UNICHEM LABORATORIES LTD 535.30 0.00 1.64 3768.82 374.10 / 616.00
AMRUTAJAN HEALTH LTD 761.05 48.91 7.62 2200.24 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6864.45 114.79 24.10 17161.13 3650.05 / 7550.00
BLISS GVS PHARMA LTD 116.40 16.01 1.23 1219.15 77.65 / 148.95
ABBOTT INDIA LIMITED 27823.05 49.22 15.98 59123.98 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 533.30
  • 26 Days 532.00
  • 10 Days 533.20
  • 50 Days 546.00
  • 12 Days 530.90
  • 100 Days 540.70
  • 20 Days 535.80
  • 200 Days 423.50
534.37
PIVOT
First Resistance 538.73
Second Resistance 542.37
Third Resistance 546.73
First Support 530.73
Second Support 526.37
Third Support 522.73
RSI 50.06
MACD -1.11
Commodity Channel Index (CCI) -21.34
ADX 6.16
Williams % R -50.00

Over 1 Month

down

-2.49

Over 3 Months

down

-1.37

Over 6 Months

down

13.89

Over 1 Year

down

39.24

Over 3 Years

down

16.97

Over 5 Years

down

24.78

UNICHEM LABORATORIES LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

UNICHEM LABORATORIES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
19.1
Promoter Holdings
70.22
FII
0.89
DII
9.77
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ipca Laboratories Limited Shareholding of Promoter and Promoter Group 3.7081011E7 52.67
Dr. Prakash Amrut Mody Shareholding of Promoter and Promoter Group 8997952.0 12.78
Hdfc Small Cap Fund Public Shareholding 5610120.0 7.97
Anita Prakash Mody Shareholding of Promoter and Promoter Group 1323400.0 1.88
Supriya Prakash Mody Shareholding of Promoter and Promoter Group 949936.0 1.35
Suparna Prakash Mody Shareholding of Promoter and Promoter Group 949936.0 1.35
Dsp Healthcare Fund Public Shareholding 735591.0 1.04
Dr. Prakash Amrut Mody - Suparna Mody Trust (promoter Trust ) Shareholding of Promoter and Promoter Group 52016.0 0.07
Dr. Prakash Amrut Mody - Shwetambari Mody Trust (promoter Trust) Shareholding of Promoter and Promoter Group 41283.0 0.06
Dr. Prakash Amrut Mody - Supriya Mody Trust (promoter Trust) Shareholding of Promoter and Promoter Group 45052.0 0.06
The Hongkong And Shanghai Banking Corp.ltd. Public Shareholding 500.0 0.0

UNICHEM LABORATORIES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2022-08-01 4.0 Final 2022-08-03 Equity shares 2021-07-22 4.0 Final 2021-07-26 Equity shares 2020-08-20 4.0 Final 2020-08-24 Equity shares 2019-07-18 4.0 Final 2019-07-22 Equity shares 2018-07-19 5.0 Final 2018-07-23 Equity shares 2017-07-13 3.0 Final 2017-07-17 Equity shares 2016-03-17 2.0 Interim 2016-03-19 Equity shares 2015-07-02 2.0 Final 2015-07-06 Equity shares 2014-07-03 4.0 Final 2014-07-07 Equity shares 2014-01-23 4.0 Interim 2014-01-24 Equity shares 2013-07-11 4.5 Final 2013-07-15 Equity shares 2012-09-13 3.0 Final 2012-09-17 Equity shares 2011-07-14 2.8 Final 2011-07-18 Equity shares 2010-10-21 3.0 Interim 2010-10-22 Equity shares 2010-05-14 7.0 Interim 2 2010-05-17 Equity shares 2009-10-27 3.0 Interim 2009-10-28 Equity shares 2009-07-09 5.0 Final 2009-07-13 Equity shares 2008-10-29 3.0 Interim 2008-10-31 Equity shares 2008-07-10 5.0 Final 2008-07-14 Equity shares 2007-03-16 5.0 Final 2007-03-20 Equity shares 2006-07-13 0.0 Final 2006-07-16 Equity shares 2005-07-14 0.0 Final 2005-07-18 Equity shares
Ex-Date Ex-Bonus Ratio
2004-03-24 2004-03-16 1:1 2000-04-20 2000-04-04 1:1 2000-04-20 2000-04-03 1:1
Ex-Date Old FV NEW FV Record Date
2010-10-21 5.0 2.0 2010-10-22 2004-03-16 10.0 5.0 2004-03-24 2004-03-16 10.0 5.0 2004-03-24

Learn More About Stocks

About UNICHEM LABORATORIES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by UNICHEM LABORATORIES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Unichem Laboratories Ltd?

Answer Field

The share price of Unichem Laboratories Ltd for NSE is ₹ 532.1 and for BSE is ₹ 531.5.

What is the Market Cap of Unichem Laboratories Ltd?

Answer Field

The market cap of Unichem Laboratories Ltd for NSE is ₹ 3,746.29 Cr. and for BSE is ₹ 3,742.06 Cr. as of now.

What is the 52 Week High and Low of Unichem Laboratories Ltd?

Answer Field

The 52 Week High and Low of Unichem Laboratories Ltd for NSE is ₹ 615.65 and ₹ 375.65 and for BSE is ₹ 616.00 and ₹ 374.10.

How to Buy Unichem Laboratories Ltd share?

Answer Field

You can trade in Unichem Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Unichem Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 39.24%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader